TBCR Reading Tools
How to cite item
Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR
+
HER2
−
metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TBCR}{79777}, author = {Balanchivadze, N., Robert, N.}, title = {Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR<sup>+</sup>HER2<sup>−</sup> metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China}, journal = {Translational Breast Cancer Research}, volume = {4}, number = {0}, year = {2023}, url = {https://tbcr.amegroups.org/article/view/79777} }